Arca
Skip to content
Tools
Tools

everX Posterior

Material, Tooth Shade, Resin. 510(k) K153127, from GC America, Inc. (Alsip, IL). Product code EBF, class 2.

As of Nov 18, 2026, K153127 is an FDA 510(k) held by GC America, Inc., substantially equivalent on May 20, 2016 after 204 days, with no recalls tied to it in FDA's recall database.

  • Review time: 204 days
  • Recalls: 0
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

everX Posterior is indicated for use as a fiber reinforced composite for the restoration of prepared carious teeth, including large posterior cavities with loss of dentin.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

1 later 510(k) summary names this device as a predicate
  • everX FlowK192260 · GC America, Inc. · Nov 22, 2019

Other EBF clearances

The newest 510(k)s for the same product code; their median review was 61 days; see every EBF device

Record

Type
Traditional
Received
Oct 29, 2015
Review panel
Dental
Regulation
21 CFR 872.3690

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.